Seelos Therapeutics Faces Liquidation as Bankruptcy Filing Confirms Investor Wipeout
Seelos Therapeutics has initiated Chapter 11 bankruptcy proceedings, signaling a probable complete loss for shareholders. The biopharmaceutical firm’s voluntary petition, filed on November 16, 2024, in US Bankruptcy Court, reveals a staggering financial imbalance that leaves little hope for recovery. The company’s disclosed financial situation paints a dire picture. According to court documents, Seelos Therapeutics…

